Natera is a San Carlos, CA-based company that is driven by a passion for elevating the science and utility of prenatal testing. The advent of the Information Age has created a paradigm shift in the fields of computing and informatics. Surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing. Until Natera.

From conception to delivery, Natera is pioneering next-generation accuracy and reliability in preconception and prenatal genetic testing services, enabling couples to be informed about their pregnancy each step of the way. The company offers a wide range of tests from preimplantation genetic diagnosis (PGD) for IVF to breakthrough advances in the field of non-invasive prenatal testing (NIPT). Using advances from the human genome project and powered by sophisticated proprietary bioinformatic algorithms, Natera’s comprehensive portfolio of tests, proven science, and experienced genetic counseling services deliver the most accurate results in the industry.

Type
Public
HQ
San Carlos, US
Founded
2004
Employees
716 (est)+52%
Natera was founded in 2004 and is headquartered in San Carlos, US

Key People at Natera

Matthew Rabinowitz

Matthew Rabinowitz

CEO
Jonathan Sheena

Jonathan Sheena

CTO

Natera Locations

San Carlos, US
Washington, US
Orange, US
Queens County, US
Mobile, US
Doylestown, US
Akron, US
Toledo, US
Cleveland, US
New York, US
Los Angeles, US
Alexandria, US
Redwood City, US
Denver, US
Austin, US
Beverly Hills, US
Santa Barbara, US
Santa Monica, US
Inglewood, US

Natera Metrics

Natera Summary

Market capitalization

$498 M

Closing share price

$9.71
Natera's current market capitalization is $498 M.

Natera Financials

Natera's revenue is $190 M in FY, 2015
FY, 2015

Revenue

$190 M

Gross profit

$77.5 M

Operating income

$-59.8 M

Operating expense total

$137 M

Net Income

$-70.3 M

Operating cash flow

$-58.2 M

    Natera Market Value History

    Natera Online Presence

    Natera Company Life

    You may also be interested in